Elaine K. Sorg Sells 7,499 Shares of AbbVie Inc. (NYSE:ABBV) Stock

Atossa Therapeutics, Inc. (NASDAQ:ATOS – Get Rating)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.75 and traded as low as $0.72. Atossa Therapeutics shares last traded at $0.74, with a volume of 238,002 shares. Analyst Upgrades and Downgrades Separately, StockNews.com raised […]

Related Keywords

Montreal ,Quebec ,Canada , ,Forecyte Breast Health Test ,Renaissance Technologies ,Atossa Therapeutics Inc ,Charles Schwab Investment Management Inc ,Millennium Management ,Nasdaq ,Atossa Therapeutics ,Get Rating ,Therapeutics Stock Down ,Street Corp ,Schwab Investment Management ,Montreal Can ,Health Test ,Atossa Therapeutics Daily ,Nasdaq Atos ,Datos ,Medical ,Stocks ,Technicals ,